Abstract
(i) medical history with regard to diabetes mellitus, peripheral ischaemia, hypertension, stroke, amputation, and other factors; a rising proportion of elderly, type-2 diabetic patients (ii) blood pressure measurements in both arms; in recent years. (iii) careful search for a suitable vein; (iv) quality of the arterial pulses along the radial, ulnar, and brachial arteries;
Patients and methods (v) phlebography in some obese patients; (vi) native X-ray of the arms to detect arterial calci- (vii)ultrasonographic evaluation of the arterial and of 799 access procedures (43%). These patients were followed venous system in both arms including arterial up until 31 July 1998 (mean follow-up 31±19.3 months). blood flow rates.
Neither PTFE nor other synthetic or biological graft material was used to establish first a-v fistulae.
Doppler/duplex investigation has recently become
Among the 347 patients with primary Brescia-Cimino an essential part of the preoperative diagnostic procedfistulae, 78 (22.5%) were diabetic patients, mainly type 2. In ure, providing information on diameter and wall struc-retrospect it was impossible to differentiate reliably between ture of the blood vessels as well as arterial blood types 1 and 2. Table 1 shows the underlying renal diseases. flow rates.
Mean age at placement was 57.8±15.1 years in the nonThis strategy had been adopted empirically. To diabetic and 62.3±12.5 years in the diabetic group. The provide information on outcome we performed an youngest patient was 10, the oldest was 93 years of age. The audit and compared the functional results of first a-v majority of patients were male. One hundred and twelve patients (41.6%) were female in the non-diabetic and 36 fistulae in non-diabetic and diabetic patients including Table 1 . Primary renal diseases patients, e.g. diabetic and elderly patients or those on immunosuppressive therapy, a single dose of an antibiotic was administered when a time-consuming revision or the Patients (n) Per cent insertion of graft material was planned. We did not administer anticoagulants or antiplatelet agents 
Patient outcome
At the end of follow-up period as of 31 July 1998, 16 of the 78 diabetic patients (20.5%) were still haemodiapatients (46.2%) were female in the diabetic population. lysed with a primary or revised a-v fistula located in Details are given in Table 2. the same extremity, as were 120 of the 269 non-diabetic For analysis we compared diabetic and non-diabetic patients (44.6%). The course of the remaining 149 nonpatients according to age, gender, access location, death, diabetic and 62 diabetic patients is shown in Table 4. complication-free interval after the first operation (primary More diabetic patients had died, had been switched patency rate), thrombotic and non-thrombotic complicato CAPD, had undergone active surgical closure of the tions, rate and type of revisions, and use of PTFE graft a-v fistula, or had received a permanent atrial singlematerial in case of revision.
Data were collected in a computer database and analysed lumen silastic catheter. More non-diabetic patients had with a professional statistical software package (SPSS 8.0; received a renal transplant and more frequently a new SPSS Inc.). Subgroups of patients were compared using the vascular access had been created in the opposite arm. log-rank test. A P value of <0.05 was considered significant. The highest mortality and the highest number of active Primary patency rates were evaluated by life table analysis closures of vascular access was found in diabetic using the Kaplan-Meier method and calculated on the basis patients with elbow fistulae ( Table 5 ) presumably as a of the 'first event' after creation of the primary a-v fistula: result of their high comorbidity. first, the group of patients still living with functioning a-v Cumulative survival rates are shown in Figure 3. fistula without revision at the end-point of 31 July 1998, and
The median survival time was 33.9 months in diabetic second, the date of the first revision due to any cause and patients, and actuarial survival was lower than in nonthe date when the patients were 'lost' due to death, renal transplantation, active closure of the a-v fistula in case of diabetic patients throughout the follow-up period of severe heart failure or steal syndrome, change to CAPD in 67 months. Follow-up covered 895.5 patient-years at some cases of fistula failure or according to the patient's risk (mean per patient 2.6 years), i.e. 738 years for preference, change to an atrial catheter in case of unsatisfactory a-v fistula function or recovery of renal function with resultant cessation of maintenance haemodialysis. Patients Table 3 . Site of primary a-v fistula lost to observation were considered as 'censored'.
All patients
Non-diabetics Diabetics n=347 n=269 n=78
Perioperative aspects anaesthesia was required in a progressively rising proportion of severely ill and elderly patients with comorbidity. Antibiotics were not used routinely. Only in high-risk Percentages are shown in parentheses. Percentages are shown in parentheses. Percentages are shown in parentheses. patients.
combined group of non-diabetic and diabetic patients non-diabetic (mean 2.7) and 157.5 years for diabetic and in diabetic patients ( Figure 5 ). patients (mean 2.0).
Primary patency rates were not significantly different between non-diabetic and diabetic patients ( Figure 4 ). Revisions The median time to first event was 45.8 months for Incidence non-diabetic and 42.3 months for diabetic patients.
The primary patency rates of wrist/forearm and In total, 146 revisions were performed in the 347 patients, i.e. an average of 0.46 revision per patient. elbow fistulae were not significantly different in the 0.42 for all patients (146/347), 0.43 for the non-diabetic (117/269), and 0.37 for the diabetic patients (29/78).
The rate of revisions per patient-year at risk is analysed in Table 7 . Overall, 0.163 revisions were performed per patient-year at risk, somewhat more in diabetic patients (0.184 vs 0.158). In other words, on average one revision was necessary every 6.1 years. The lowest rate of revision was found in the diabetic patients with wrist a-v fistulae, i.e. 0.078 per patient year at risk, and the highest rate was in the diabetic patients with a primary elbow fistula, i.e. 0.234. That means one revision every 12.8 vs 4.3 years.
The number of revisions concerning the 202 primary wrist/forearm a-v fistulae and the 145 elbow region fistulae is shown in Table 8 . There were no significant differences with respect to the frequency of revisions between non-diabetic and diabetic patients regarding either wrist/forearm or elbow fistulae. 
Types of revision
At the end of the observation period 237/347 patients A first revision was performed in 110 patients. (68.3%) still had a functioning a-v fistula without any Indications are listed in Table 9 . Thirty-five patients revision. In the remaining 110 patients (88 non-diabetic with access thrombosis and two patients with infection and 22 diabetic patients), 146 revisions were necessary underwent emergency operations (33.6%). This meant (117 and 29 respectively). In these patients, the rate of a (first) revision rate per patient-year of 0.039 due to revisions per patient was 1.3 in non-diabetic and dia-thrombosis. In the remaining 73 patients (66.4%) electbetic patients respectively ( Table 6 ). The rate of revi-ive revision was mainly indicated for correction of sion for the total number of patients per group was venous stenoses, including 22 patients with long segment stenoses and 14 patients with post-anastomotic stenoses. In 10 patients, the indication was correction Percentages are shown in parentheses. the indications were correction of a steal syndrome or that more patients with an elbow fistula required a first revision to correct a steal syndrome, i.e. seven vs of cardiac failure secondary to a high fistula flow rate.
Some differences were noted between non-diabetic three patients (14.9 vs 4.8%).
Repair of aneurysm, superficialization of the basilic and diabetic patients. While 33 non-diabetic patients (37.5%) underwent emergency first revision due to vein in the upper arm, and active closure of the anastomosis were required in 17 patients (36.2%) with fistula thrombosis, this occurred only in two diabetic patients (9.1%), a rate per patient-year of 0.045 vs primary elbow fistulae, but was not necessary in the patients with wrist/forearm fistulae. 0.013. Correction of post-anastomotic and long segment stenoses (typical first complications of wrist/ Analysis of the 35 thrombotic events leading to a first revision reveals that early thrombosis (<4 weeks) forearm fistulae) was necessary in 35 non-diabetic vs only in one diabetic patient, i.e. 39.8 vs 4.5%, possibly was seen only in 7/347 patients, i.e. 2%, and in most cases poor veins had been noted during surgery. No because elbow fistulae were more frequently created to obtain initially a high blood flow in diabetic patients. diabetic patient suffered from early thrombosis. In the remaining 28 patients first revision was necessary to In contrast, more diabetic patients required revision to correct a steal syndrome, i.e. seven diabetic vs three correct late thrombosis occurring between 1.9 and 46.6 months after creation of the first anastomosis (10 non-diabetic patients (31.8 vs 3.4%) or closure of a-v fistula, i.e. five diabetic and two non-diabetic patients patients during the 1st, 12 during the 2nd, four patients during the 3rd, and two patients during the 4th year). (22.7 vs 2.3%). This was necessary mainly because of symptoms of peripheral ischaemia. Correction of In the 202 patients with a primary wrist/forearm fistula, 27 patients had to undergo first revision to venous hypertension and of post-anastomotic stenoses was required only in non-diabetic patients. correct a thrombosis (13.4%) vs only 8/145 patients with an elbow fistula (5.5%). Early thrombosis (<4 Remarkable differences were observed according to the primary location of the a-v fistula: 63/110 patients weeks) was never observed in patients with a primary elbow anastomosis. undergoing a first revision had a wrist/forearm fistula and 47 a primary anastomosis in the elbow region.
Of the 10 cases with steal syndrome necessitating revision, seven patients were diabetic and three nonFistula thrombosis was observed in 27 patients with a wrist/forearm (42.9%), but in only eight patients with diabetic. The interval between creation of the anastomosis and first revision ranged from 6.5 to 18.6 months a primary elbow fistula (17%), and the same was true for the long-segment and post-anastomotic stenoses for non-diabetic and from 4.2 to 26.9 months for diabetic patients. Three patients had a primary wrist/ (23.8 vs 14.9% and 20.6 vs 2.1%). It is not surprising forearm fistula (two non-diabetic and one diabetic access surgery. Adams et al. [1] reported disappointing results of wrist a-v fistulae when only 49 out of 101 patient), and seven patients had a primary elbow anastomos s (one non-diabetic and six diabetic attempts at a functioning wrist fistula were successful.
A higher initial success rate was reported for antecupatients); two of these had a Gracz type anastomosis (one non-diabetic and one diabetic patient).
bital fistulae; at this site 19 out of 26 fistulae were usable. Based on such reports many authors recom-A second revision was required in 28/347 patients (8.1%), i.e. 22 non-diabetic and six diabetic patients. mended and performed primary PTFE bridge fistulae in up to 80% of diabetic patients [2] . Windus raised The figures are too small for further analysis. It may be of interest to note that six thrombotic events were the sceptical question 'if conventional wisdom states that primary arteriovenous fistulae are still the best observed (21.4%) whereas eight patients underwent a second elective revision to correct a clinically relevant vascular access option for haemodialysis, why do the majority of procedures involve prosthetic graft fistula stenosis (28.6%). In five patients closure of the anastomosis was necessary; in four diabetic patients placement?' [3] . A similar opinion was expressed by Conlon and Schwab [4] . Leapman et al. [5] came to because of peripheral ischaemia and in one nondiabetic patient because of venous hypertension the conclusion 'that the arteriovenous fistula is not a panacea for vascular access' and 'that diabetics and resulting from obliteration of the superficial veins beyond the level of the elbow. Three non-diabetic elderly individuals are particularly vulnerable to poor outcomes with the arteriovenous fistula, and other patients underwent superficialization of the basilic vein in the upper arm. There were variable indications for access devices should be considered for this group of patients on hemodialysis'. To counter such opinion, second revisions in the remaining single patients.
Six patients underwent three revisions, only one the NKF-DOQI Clinical Practice Guidelines for Vascular Access [6 ] stated that 'primary a-v fistulae patient a fourth and fifth revision. Thus, an analysis will not give comparable results.
should be constructed in at least 50% of all new patients elected to receive haemodialysis as their initial Prosthetic grafts were never used for creation of the first a-v fistula. Graft material, exclusively PTFE, was form of renal replacement therapy. Ultimately, 40% of prevalent patients should have a native a-v fistula'. required in 12/347 patients (3.5%) respectively in 13/146 revisions (8.9%).
We strongly disagree with the above negative attitudes. Based on the evidence presented above we In the 110 first revisions, PTFE graft material was inserted in six patients (5.5%): in one patient an upper conclude that a primary native a-v fistula can be created in virtually all diabetic patients. We emphasize arm a-v bridge graft was required, in four patients segmental veno-venous insertion was performed using that we were never obliged to use a PTFE graft to create a first fistula in a diabetic patient. PTFE of variable length, and in one patient with peripheral ischaemia a banding procedure was perHaving disposed of the myth concerning the necessity of synthetic grafts, we wish to address the issue of formed using a PTFE cuff. In the 28 second revisions PTFE prosthetic material was chosen in seven patients the site at which the primary a-v fistula should be created in a diabetic patient. Our initial attempts at (25%): in one patient with a long-segment veno-venous PTFE segment, thrombectomy was required, two creating primary wrist fistulae encountered major obstacles, i.e. high rates of early thrombosis and reduced patients received a graft in a-v position, and in four patients, venous stenoses/aneurysms were repaired by blood flow rates secondary to inadequate venous remodelling and dilatation. This constellation pointed veno-venous insertion of a PTFE prosthetic graft segment ( Table 10) .
to the feeding artery as the culprit. The problems were compounded by the increasing age of the diabetic population and by the poor state of peripheral veins Discussion as a result of repeated previous blood sampling and intravenous therapy during preceding hospitalizations. In 1977 Anderson et al. [7] measured the blood flow Little attention has been paid in the literature to the rate in surgically created a-v fistulae. He and subspecial and demanding problem of vascular access in sequent authors [8] found a flow rate in the radial the diabetic haemodialysis patient. Initial reports artery of 20-30 ml/min. This increased up to emphasized the generally poor outcome of vascular 200-300 ml/min immediately after creation of an a-v fistula, and after maturation reached flow rates up to anastomosis in the majority of diabetic patients. Such proximally located fistulae are only safe, however, if account for closure of the fistula. Indeed, the primary the length of the anastomosis is restricted to about 4 patency rate was nearly identical in non-diabetic and or 5 mm, i.e. the approximate diameter of the bra-diabetic patients. This was true both for wrist/forearm chial artery. and for elbow fistulae. On the issue of which vein to select for anastomosis, Apart from fragmentary reports [11, 12] which can the elbow region offers many veins capable of permit-be criticized on several accounts, no information is ting sufficient yet not excessive fistula flow, allowing available with which we could compare our experience for gradual dilatation of the vein. Because cannulation concerning fistula revision, but the above results are can be performed easily early on, we prefer the cephalic less catastrophic than anticipated by the uncontrolled vein if this is available.
opinion of clinical nephrologists. Nevertheless, several I wish to comment on several points that are pertin-comments are appropriate. ent to the question of whether our results can be Remarkably, no significant difference was noted generalized. All the above access procedures were between non-diabetic and diabetic patients in the rate performed by one nephrologist, so that uniformity of of revisions per patient year at risk. Indeed, the lowest procedures was guaranteed.
rate of revision was found for diabetic patients with Since our institution has a CAPD programme, the wrist a-v fistulae. This may be due at least in part to proportion of diabetic patients, i.e. 78/347 (22%), may selection, because patients with anticipated poor arternot be representative of the entire population of dia-ial inflow were selected for primary elbow fistulae. This betic patients, but selection for CAPD was based on low rate is remarkable in view of the results of Sands the criterion of anticipated difficulties with creating and Miranda [13] , who reported 3.6 revisions per vascular access only in a few patients. The great patient year at risk because of thrombosis of PTFE majority of first a-v fistulae were created in the bridge grafts. forearm/wrist region, but the proportion was considerRecently Schwab [14] reported that 80-85% of all ably less in diabetic patients. The elbow region was access complications and failures are secondary to primarily chosen in 32% of the non-diabetic and 74% thrombosis. In our experience amongst the 110 patients of the diabetic patients. In 50% of these diabetic with first revisions, only 35 patients (32%) had thrompatients, we adopted the Gracz procedure [9] , which bosis. If one assumes that early thrombosis is often offers several advantages: the anastomosis is buried in due to surgical problems, it is of particular note that the depths of the elbow region. Only the superficial only seven (2%) of the 347 non-diabetic and diabetic venous system is cannulated, thus reducing the risk of patients had an early thrombosis, i.e. within the first accidental puncture of the anastomosis that is present month, and this was seen only in non-diabetic patients. whenever the anastomosis is located subcutaneously No diabetic patient had early thrombosis of primary (e.g. between the proximal radial artery and the ceph-wrist or elbow fistula. In the latter cases, the greater alic antebrachial vein or the brachial artery and the diameter of the vessels and the higher blood flow rate initial portion of the basilic vein). We adopted a may protect against thrombotic occlusion. Late thrommodification of the original technique: the perforating bosis causing first revision occurred in only two of 78 vein is cut before it enters the deep venous system. (2.6%) diabetic patients. This limits the length of the anastomosis to the diaMajor indications for elective first revision were meter of the perforating vein, i.e. 3-5 mm. In most clinical signs of fistula dysfunction ('failing fistula'), cases the vein is anastomosed to the brachial artery. e.g. post-anastomotic and long-segment stenoses of Because of considerable interindividual topographical forearm veins. This was less frequent for elbow a-v variation, in some patients the proximal radial artery fistulae. If forearm anastomoses are created with tiny or even the ulnar artery were used. Our positive veins, injury to the perivenous nutritive tissue and/or experience is in agreement with the results of Elcheroth pre-existing injury to the vein may prevent adaptive et al. [10] . dilatation of the vein, create a low-flow situation, and Selection of the type of fistula must take into considpredispose to thrombosis and stenosis. eration the reduced life expectancy of diabetic patients.
In view of the high rate of peripheral atherosclerotic At the end of the follow-up period, only 20.5% of arterial lesions it is not surprising that the first revision diabetic patients were alive with a functioning primary due to peripheral ischaemia had to be performed more or revised vascular access in the same extremity, comfrequently in diabetic patients, and this was particularly pared with 44.6% of non-diabetic patients. If one seen in high-flow elbow fistulae. This complication anticipates limited survival on haemodialysis, it seems arose in 9% of diabetic patients. Repair of aneurysms, reasonable to create the vascular access in the elbow superficialization of the basilic vein in the upper arm, region. This approach offers a higher delivered dose and active closure of the anastomosis were not necesof dialysis and a better quality of life than failed, nonsary in any diabetic patient with a wrist/forearm fistula, maturing peripheral anastomoses. In the majority of but there was a definite risk in patients with primary our patients with elbow fistulae, the first cannulation elbow fistulae. of the superficially located cephalic vein was possible A second revision was necessary in 28/347 (8.1%), within 2-14 days after the operation. We feel that 22 non-diabetic and six diabetic patients. Six patients there is nothing mysterious about diabetic patients and that the putative endothelial cell dysfunction does not underwent three revisions, only one patient a fourth and fifth revision. These figures are too small to permit References any generalized conclusion.
